YPC-14383-06160
4 vaccinations
2 coded responses
27 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 921 / CA
- Registered
- 2021-05-07
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Registered dependents
89P-14123-66305
Child or adolescent in my care · Female · 2022-09-03
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-30
Dose 2 — Pfizer-BioNTech
-
2021-05-07
Registered in v-safe
- 2021-05-07
-
2021-05-14
Survey response — day 14, dose 2MedDRA: Vaginal haemorrhage — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Light vaginal spotting about 1.5 weeks after second dose was received.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-14
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-27
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-08-06
-
2021-12-07
Dose 3 — Pfizer-BioNTech
-
2021-12-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-12-09
- 2021-12-11
- 2021-12-23
- 2021-12-28
- 2022-01-04
- 2022-01-11
-
2022-01-20
Survey response — day 42, dose 3MedDRA: Ear discomfort, Oropharyngeal pain, Rhinorrhoea, Sneezing — Feeling: FairFree text: Sore throat Ear pressure Sneezing Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-12-09
-
2023-03-17
Dose 4 — Moderna
- 2023-03-17
- 2023-03-19
- 2023-03-20
- 2023-03-21
- 2023-03-22
- 2023-03-23
- 2023-03-24
- 2023-03-31
- 2023-04-07
- 2023-04-21
- 2023-04-28
- 2023-06-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech | |
| 3 | 2021-12-07 | Pfizer-BioNTech | No |
| 4 | 2023-03-17 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-14 | Unsuccessful |
Free text
Release 8 — day 14, dose 2
Symptoms: Light vaginal spotting about 1.5 weeks after second dose was received.
Release 10 — day 42, dose 3
Symptoms: Sore throat Ear pressure Sneezing Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ear discomfort | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Vaginal haemorrhage | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release